Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672313 | SCV000797410 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-01-26 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005056417 | SCV005726629 | uncertain significance | not specified | 2024-11-18 | criteria provided, single submitter | clinical testing | Variant summary: USH2A c.8212G>A (p.Asp2738Asn) results in a conservative amino acid change located in the Immunoglobulins domain (IPR013783) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250850 control chromosomes. c.8212G>A has been reported in the presumed compound heterozygous state in the literature in at least 1 individual affected with Usher Syndrome (example, Huang_2013). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 23737954). ClinVar contains an entry for this variant (Variation ID: 556319). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |